149 Fifth Avenue
Suite 500
New York, NY 10010
United States
212 994 8200
https://www.protagenic.com
版塊: Healthcare
行業: Biotechnology
全職員工: 1
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Garo H. Armen Ph.D. | Co-Founder & Executive Chairman of the Board | 無 | 無 | 1953 |
Dr. Alexander Kenneth Arrow C.F.A., M.D. | CFO & Secretary | 150k | 無 | 1971 |
Dr. Andrew Slee Ph.D. | Chief Operating Officer | 無 | 無 | 1950 |
Dr. Robert Benjamin Stein M.D., Ph.D. | Chief Medical Officer & Director | 無 | 無 | 1951 |
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
截至 無 止,Protagenic Therapeutics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。